Should Sugary Drinks Be Taxed?
Taxing sugary drinks may lower consumption and, in turn, reduce obesity, type 2 diabetes and even tooth decay, according to a new World Health Organization (WHO) report.
Popular Diabetes Rx May Not Treat Heart Failure
Liraglutide (brand name Victoza), a medication currently used to treat type 2 diabetes, may not be as beneficial in those with heart failure than earlier studies have reported.
New Type 2 Diabetes Rx Gets Green Light
The US Food and Drug Administration has approved a new treatment option for type 2 diabetes.
Men, Sleep and Diabetes Risk
For men, sleeping too much or too little could raise diabetes risk, a new study found.
Jentadueto XR Gets FDA Approval
The US Food and Drug Administration has approved a once-daily form for Jentadueto.
Diabetes Rx May Pose Amputation Risk
The US Food and Drug Administration (FDA) has issued an alert for a medication used to treat type 2 diabetes.
Get Moving to Prevent Diabetes
Echoing what past studies have suggested, a new study found that being fit may send diabetes and prediabetes running.
An In-Depth Look at Childhood Obesity
With nearly one-third of all US children ages 2 to 19 currently overweight or obese, childhood obesity has become an epidemic. Fortunately, this condition is preventable in many cases.
Weight Loss: A Little Could Do a Lot
For overweight patients, attempting to shed those extra pounds can be daunting. But even dropping a few can have profound health benefits, new evidence suggests.
A Potential New Use for Pioglitazone
Sometimes a medication used to treat one condition can also help with another. That might be the case with pioglitazone (brand name Actos).